VaxEquity and CPI Announce Innovate UK Grant to Accelerate Next Generation RNA Vaccines and Therapeutics

Cambridge, England, 5 June 2023 – VaxEquity, developing transformative RNA vaccines and therapeutics based on its next generation self-amplifying RNA (saRNA) platform, and CPI, the UK’s leading independent technology innovation centre, today announce a grant of approximately £700K from Innovate UK. The grant will fund a collaborative project to advance the manufacturing process for RNA vaccines and therapeutics.